sp
127
bradykinin
facts
sole
london
medicine
conclusions
threshold
af
charges
previous
verified
reduce
350
access
discretion
153
wild
311
accessibility
breast
res
address
lyzed
circulating
parker
type
intervene
trigger
nhanes
2002
option
denus
supported
nature
note
there
regi
regardless
mended
hyattsville
adenosine
appropriate
mph
angioedema
grapes
kuczmarski
dence
cutoff
video
vascular
duffy
conditions
treated
protection
source
bmi
outcome
occur
meeting
education
stron
nar
varying
friedman
amount
warner
vari
dis
few
whom
authors
show
reducing
clines
sufficient
chicago
gests
initiate
001
even
contact
crease
fla
1991
should
flushing
dj
gest
suming
usefulness
liquid
editing
episode
interscience
final
tea
semisweet
468
therapies
men
resulting
already
sci
clinical
munities
knowledge
danger
606
index
boothroyd
antagonists
proposed
known
unclear
word
additional
signifi
vegetable
sd
sented
visits
whooley
reporting
dade
542
hemostasis
continues
estimating
aromatization
526
line
108
exposure
philadelphia
massachusetts
result
1447
physicians
kl
vey
references
text
yih
findings
set
deeb
fering
oddone
1988
gov
plus
agent
659
fme
persist
quantitatively
could
expression
does
dc
rates
foods
performed
logical
port
fewer
ceptor
agement
vation
interaction
research
young
principally
center
trials
survey
sion
ja
5225
metabolism
inhibit
indicated
mm
appreciate
statistics
both
program
006
marc
decisions
telephone
substance
although
ghc
important
old
vaccine
prior
stimulated
reactivation
lw
comparison
1550
all
relax
programs
overweight
cotics
regular
disseminated
relief
would
2792
pairwise
1059
adapted
systems
duplicate
reactivated
significantly
total
concentra
support
mcw
physician
nesbitt
control
including
global
trations
unless
weinberger
sciences
adipose
third
hulley
polymerize
mortality
bm
hours
ovarian
disease
supervising
black
agree
boston
planning
467
nificant
boulanger
centers
approach
multiple
efficacy
hot
cases
35747
mandates
methods
recently
sug
prevention
opiates
rather
tolerate
sions
age
decreasing
call
recommended
higher
comment
wallis
tests
mental
distributed
van
results
dk
relative
attenuated
inverse
significant
usual
1545
multidisciplinary
va
hope
contained
d4
modelling
revise
protecting
post
funding
induced
measures
they
oxide
aisha
inhibitor
adverse
tained
leu
ventricular
geriatric
davis
experience
freedman
individual
who
aa
phd
experiencing
previously
plasma
collagen
simple
editors
brumley
ined
995
pract
strive
specialized
pw
vol
suggest
increases
release
clinician
amounts
coll
cella
ining
je
failure
assn
factors
group5
commonly
expected
submitted
main
1998
melinda
advance
pre
epinephrine
beverages
discussing
alternative
studies
mail
effects
597
receiving
111
acces
telecare
schramm
date
elu
many
simon
arbs
lungu
life
subject
stat
prac
elderly
symptoms
system
dracup
flashes
simpson
widespread
hemo
affairs
675
tative
disclosure
college
enrolled
provide
antithrombotic
isolated
categorized
appears
national
galil
ma
noids
hefter
145
risk
care
menopause
mars
kj
identified
chromatography
poorly
2212
sig
permits
focused
optimize
fast
similarly
patient
measured
illnesses
presented
glycoprotein
study
pharm
dw
affect
vaccinated
continuation
populations
flexibility
southern
family
152
unchanged
california
case
respon
flavonoids
variety
intake
tients
resource
effectively
surface
combination
roberta
mass
2113
about
jane
models
sites
brigham
120
metabolite
carl
hormonal
blockers
hormone
254
ensuing
kruskal
azari
md
beyond
holt
menopausal
original
increase
postmeno
adp
pharmacy
soc
lawson
cough
cidated
c4
200
providing
suggested
525
2001
edema
published
monitoring
improved
1239
wisconsin
purple
multicenter
1245
truly
containing
hypothesis
427
lewis
includes
understood
cost
active
impact
formulation
evident
fcrpath
1982
letters
under
pharmacother
carmen
circu
contrast
hygiene
please
drs
prevalence
chips
decompensation
reacti
our
its
med
depressive
aside
group
home
sch
ease
large
cartridge
medical
f1
reversed
soon
pausal
records
end
treatment
theory
strain
baker
permanente
reach
monitor
funded
great
zoster
long
particular
hunt
without
than
specialists
force
milwaukee
reductions
measure
fam
downey
monitored
department
laryngoscope
history
procyanidins
tschampel
letter
thun
reduction
tion
duction
follow
continued
calle
several
flawed
concen
richard
fax
2000
mediated
leagues
lead
caution
cdc
strata
plate
baseline
copy
visconti
wishes
eicosanoid
might
practice
following
280
moser
471
data
derek
mechanism
jgc
treat
readmissions
whose
council
after
apples
karin
immunogenicity
juice
heart
nant
ceed
keaney
challenging
analysis2
iiia
shear
jb
grants
encourage
dorsal
1441
334
msc
progestin
second
difference
patnaik
1997
cific
interven
reported
takes
pharmd
suf
judd
sure
work
cian
licensed
188
whole
observational
sodes
rein
new
lipidol
evaluation
640
thoughtful
org
service
whether
vital
biologically
pro
send
states
respectively
2018
needed
464
exam
april
dyspnea
specifically
settings
was
experienced
705
lazarus
admis
mathematical
enhance
two
conclusion
407
cir
each
count
cited
miller
describes
erlik
hospice
calls
seward
pfa
elizabeth
thearubigins
sicians
resulted
providers
boost
grady
discussions
tropical
schmitz
angiotensin
criteria
generally
ama
describe
full
progressively
613
half
eperc
recognized
jerant
limit
gen
exceed
available
consistent
chiu
however
testing
ered
patients
sheryl
compared
determinant
ez
ts
lurie
vet
colleagues
did
external
any
outlying
site
more
year
material
subjects
1047
patterns
let
groups
laboratory
weissman
regarding
sur
among
report
class
varicella
citations
detailed
most
bush
col
tg
1729
had
approval
information
528
armstrong
curr
closure
chronic
january
collaborative
matic
estradiol
palliative
phase
will
much
325
378
infected
1233
part
lynne
fa
cohorts
sumption
average
iii
fatal
practices
left
endog
questioned
cause
sample
drug
upon
only
emphasis
ill
fect
status
enzyme
expertise
flavanol
persis
produced
160
signed
jama
boosting
sometimes
culation
reasonable
immunity
producing
nephrine
jumaan
theaflavins
12e
alike
wildt
epidemiol
480
advanced
indeed
making
ratio
hackettstown
concern
systematic
2798
state
tal
appropriateness
probably
cardiology
ranks
john
absorption
enous
chemic
reserved
numerous
associated
2213
direct
merck
hz
obesity
senior
modify
aspi
nigel
blood
increasing
weeks
ci
wk
less
depending
avert
due
brooks
400
analysis
krowiak
eicosanoids
introduction
151
increased
frequent
six
287
estrone
moreover
paper
quality
received
515
extreme
outpatients
food
sarah
update
replacement
next
clo
hlatky
decline
thus
daily
androgens
110
1995
value
oral
flavo
contain
iib
2210
changes
41st
calif
oka
negligible
coronary
same
comor
rich
ambulatory
assuming
familiarity
prostaglandin
epidemiology
hour
others
brisson
2443
congestive
reverses
bhc
inflammatory
congeni
shingles
individuals
centralized
adults
secondary
applied
pr
some
function
committee
lancet
bs
663
evi
kemia
improvement
financial
insen
histamine
antioxidant
given
against
ensure
moni
certainly
rashes
practicing
dra
rodriquez
250
evalua
meldrum
brfss
larussa
society
dedication
benefits
focus
keto
basis
article
suspect
between
infectious
manson
space
thors
reply
591
likely
func
34th
kk
resources
102
atlanta
keen
clin
subclinically5
discuss
fail
chocolate
163
nitrate
obstet
dm
influenced
levels
titre
rapidly
hardy
dose
recom
com
aspirin
trial
teo
offer
user
eugenia
dramatic
postmenopausal
flavanols
249
watson
cardiol
publication
140
circulation
predomi
women
www
older
gay
public
lating
gynecol
2101
why
prostacyclin
children
nitric
credentials
telephonic
cooperative
inhibi
readmission
2209
agents
lower
must
specific
krause
england
body
paglieroni
internal
nmol
inhibition
using
reanalysis
american
varmer031795sba
concurrent
since
tatham
platelet
critical
1996
concept
physi
flegal
concentrations
ing
infect
united
other
transient
term
normally
628
clinicians
except
intact
university
clinics
troduction
vzv
assumptions
readmis
1234
literature
another
125
kasper
inhibitors
cardiovascular
immunized
initiation
nj
nificance
kris
limited
teams
munization
acc
velop
ann
behring
peripheral
nutr
aperture
erans
within
specifications
latent
stricker
il
mh
unvaccinated
points
etiology
morbidity
reactivity
proc
washington
stratified
consid
hibitor
peterson
titration
select
estrogen
response
because
recent
rights
potential
steinberg
newer
tukey
engl
immunity6
sharp
variance
metabolites
palliation
level
stevenson
none
wg
followed
patel
smaller
stanford
phy
nutrition
harold
abridgment
trial4
immunization
156
management
hospital
one3
decrease
emergency
guidelines
marker
occlude
risks
reactivates
tection
authorship
jf
gershon
herpes
nal
jacobs
unique
scores
indicates
optimal
220
used
figure
cantly
story
annual
1989
evolved
executive
december
considerable
ek
examined
ongoing
responsible
derived
man
galanos
rela
alleviated
tice
incidence
copyright
july
548
http
transiently
60610
1999
pdf
may
re
acad
different
believe
broader
depression
ii
statewide
nurses
trained
hers
geriatrics
requested
gerstenblith
ace
conduct
fruit
spe
seattle
mbbs
depletion
1992
ag
vleeming
further
10984
perspectives
base
november
hard
anova
number
endothelial
developing
endothelium
rin
estrogens
summary
683
attempted
exter
acknowledgment
prolong
sizes
managed
professionals
897
now
312
angio
questionable
population
test
beneficial
fluctuations
flavonoid
sa
100
300
henderson
how
comprehensive
their
605
nurse
cl
downloaded
administration
antimicrobial
sba
instruc
spinler
unknown
included
694
point
171
performance
ness
dysfunction
far
booster
required
also
tissue
related
functions
mfphm
cancer
wun
but
analytical
membrane
small
over
found
ganglia
tenuated
ischemic
association
prevent
1731
tor
instead
creased
opin
statistical
sup
repeated
leukotriene
cline
ask
receive
cocoa
acknowledged
managing
automated
include
evidence
his
low
colleagues1
rm
651
through
while
await
sitive
allows
hydralazine
500
based
2211
assigned
reactivate
transfer
school
depend
1994
pl
finally
safer
priority
tions
klinman
chemo
field
once
hospitalization
transplantation
edmunds
greater
such
arb
heterogeneity
150
butler
cber
stroke
decreased
accumulation
virus
successful
vanhoutte
1965
catechin
amsterdam
sj
troinano
intervention
see
statement
assessed
deer
combining
creases
611
modeled
hance
exog
time
communicable
ment
interim
ze
114
either
detect
health
shortly
human
review
evaluating
ascherio
ana
li
narcotics
artery
104
scientific
dept
complex
tent
annunziato
mechanisms
aha
wj
thinner
cell
stitute
veillance
task
nohria
has
reaction
wharton
adult
unpublished
dunn
receptor
holbrook
103
stage
specialist
section
size
editor
cidence
generalizability
pennsylvania
jects
reprinted
prostacylin
healthcare
joshipura
ure
raise
reliably
completely
doses
words
safety
short
trends
use
alongside
defects
518
vaccination
resultant
169
411
mombouli
384
diphosphate
fda
rodriguez
majority
converting
approaches
rehospitaliza
tually
epi
therapy
nursing
generalists
con
conference
10980
stephen
bidity
mcalister
essential
sibility
etherton
vittinghoff
friesinger
replace
randomized
establish
pediatr
observed
282
669
chickenpox
vanol
stasis
us
interventions
chin
mean
epidemio
via
responsibility
cannot
along
epicatechin
not
meta
mark
surveillance
years
activation
2456
edu
wom
inc
division
range
returned
root
particularly
severe
effect
services
transmission
reduced
ej
live
declined
cation
times
piano
carroll
community
stitutes
e4
quiescence
consumption
inhibits
403
success
al4
represents
persons
lt
abstract
team
natl
place
primary
statistically
high
help
anthony
first
consumed
thin
overall
sub
erally